Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro

被引:3
|
作者
Budai-Szucs, Maria [1 ]
Berko, Szilvia [1 ]
Kovacs, Anita [1 ]
Jaikumpun, Pongsiri [2 ]
Ambrus, Rita [1 ]
Halasz, Adrien [3 ]
Szabo-Revesz, Piroska [1 ]
Csanyi, Erzsebet [1 ]
Zsembery, Akos [2 ]
机构
[1] Univ Szeged, Inst Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary
[2] Semmelweis Univ, Dept Oral Biol, Budapest, Hungary
[3] Natl Koranyi Inst Pulmonol, Budapest, Hungary
关键词
Cystic fibrosis; Rheology; Hypertonic salt solutions; Bicarbonate; In vitro treatment; MUCUS; SECRETION;
D O I
10.1186/s12890-021-01599-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Cystic fibrosis (CF) is a life-threatening multiorgan genetic disease, particularly affecting the lungs, where recurrent infections are the main cause of reduced life expectancy. In CF, mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein impair transepithelial electrolyte and water transport, resulting in airway dehydration, and a thickening of the mucus associated with abnormal viscoelastic properties. Our aim was to develop a rheological method to assess the effects of hypertonic saline (NaCl) and NaHCO3 on CF sputum viscoelasticity in vitro, and to identify the critical steps in sample preparation and in the rheological measurements. Methods Sputum samples were mixed with hypertonic salt solutions in vitro in a ratio of either 10:4 or 10:1. Distilled water was applied as a reference treatment. The rheological properties of sputum from CF patients, and the effects of these in vitro treatments, were studied with a rheometer at constant frequency and strain, followed by frequency sweep tests, where storage modulus (G '), loss modulus (G '') and loss factor were determined. Results We identified three distinct categories of sputum: (i) highly elastic (G ' > 100,000 Pa), (ii) elastic (100,000 Pa > G ' > 1000 Pa), and (iii) viscoelastic (G ' < 1000). At the higher additive ratio (10:4), all of the added solutions were found to significantly reduce the gel strength of the sputum, but the most pronounced changes were observed with NaHCO3 (p < 0.001). Samples with high elasticity exhibited the greatest changes while, for less elastic samples, a weakening of the gel structure was observed when they were treated with water or NaHCO3, but not with NaCl. For the viscoelastic samples, the additives did not cause significant changes in the parameters. When the lower additive ratio (10:1) was used, the mean values of the rheological parameters usually decreased, but the changes were not statistically significant. Conclusion Based on the rheological properties of the initial sputum samples, we can predict with some confidence the treatment efficacy of each of the alternative additives. The marked differences between the three categories suggest that it is advisable to evaluate each sample individually using a rheological approach such as that described here.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
    Reeves, Emer P.
    Molloy, Kevin
    Pohl, Kerstin
    McElvaney, Noel G.
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [32] Physostigmine, sodium bicarbonate, or hypertonic saline to treat diphenhydramine toxicity
    Holger, JS
    Harris, CR
    Engebretsen, KM
    VETERINARY AND HUMAN TOXICOLOGY, 2002, 44 (01) : 1 - 4
  • [33] Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis
    Ho, SA
    Ball, R
    Morrison, LJ
    Brownlee, KG
    Conway, SP
    PEDIATRIC PULMONOLOGY, 2004, 38 (01) : 82 - 87
  • [34] Effects of hypertonic saline on sputum clearance in patients with bronchiectasis
    Serrano, Victoria Alcaraz
    Cortina, Beatriz Herrero
    Casamitjana, Jordi Vilaro
    Mayor, Edmundo Rosales
    Marti, Antoni Torres
    Polverino, Eva
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [35] Effects Of Hypertonic Saline On Sputum Clearance In Patients With Bronchiectasis
    Alcaraz, V.
    Herrero, B.
    Vilaro, J.
    Rosales-Mayor, E.
    Torres, A.
    Polverino, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] Mucus clearance and lung function in cystic fibrosis with hypertonic saline
    Donaldson, SH
    Bennett, WD
    Zeman, KL
    Knowles, MR
    Tarran, R
    Boucher, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03): : 241 - 250
  • [37] DURABILITY OF HYPERTONIC SALINE FOR ENHANCING MUCOCILIARY CLEARANCE IN CYSTIC FIBROSIS
    Brown, A. W.
    Laube, B. L.
    Zeman, K.
    Lechtzin, N.
    Sharpless, G.
    Wu, J.
    Donaldson, S. H.
    Bennett, W. D.
    PEDIATRIC PULMONOLOGY, 2010, : 303 - 304
  • [38] Tolerance of 7% Hypertonic Saline in Pediatric Cystic Fibrosis Patients
    Guevara, Maria Talamo
    McColley, Susanna A.
    Rychlik, Karen
    Savant, Adrienne P.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2020, 33 (02) : 63 - 68
  • [39] Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis
    Suri, R
    Marshall, LJ
    Wallis, C
    Metcalfe, C
    Bush, A
    Shute, JK
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) : 352 - 355
  • [40] Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis
    Suri, R
    Metcalfe, C
    Wallis, C
    Bush, A
    PEDIATRIC PULMONOLOGY, 2004, 37 (04) : 305 - 310